Cerebral vascular malformations: pathogenesis and therapy

Abstract Cerebral vascular malformations (CVMs), particularly cerebral cavernous malformations and cerebral arteriovenous malformations, pose significant neurological challenges due to their complex etiologies and clinical implications. Traditionally viewed as congenital conditions with structural a...

Full description

Saved in:
Bibliographic Details
Main Authors: Qiheng He, Ran Huo, Yingfan Sun, Zhiyao Zheng, Hongyuan Xu, Shaozhi Zhao, Yang Ni, Qifeng Yu, Yuming Jiao, Wenqian Zhang, Jizong Zhao, Yong Cao
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:MedComm
Subjects:
Online Access:https://doi.org/10.1002/mco2.70027
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850073387603329024
author Qiheng He
Ran Huo
Yingfan Sun
Zhiyao Zheng
Hongyuan Xu
Shaozhi Zhao
Yang Ni
Qifeng Yu
Yuming Jiao
Wenqian Zhang
Jizong Zhao
Yong Cao
author_facet Qiheng He
Ran Huo
Yingfan Sun
Zhiyao Zheng
Hongyuan Xu
Shaozhi Zhao
Yang Ni
Qifeng Yu
Yuming Jiao
Wenqian Zhang
Jizong Zhao
Yong Cao
author_sort Qiheng He
collection DOAJ
description Abstract Cerebral vascular malformations (CVMs), particularly cerebral cavernous malformations and cerebral arteriovenous malformations, pose significant neurological challenges due to their complex etiologies and clinical implications. Traditionally viewed as congenital conditions with structural abnormalities, CVMs have been treated primarily through resection, embolization, and stereotactic radiosurgery. While these approaches offer some efficacy, they often pose risks to neurological integrity due to their invasive nature. Advances in next‐generation sequencing, particularly high‐depth whole‐exome sequencing and bioinformatics, have facilitated the identification of gene variants from neurosurgically resected CVMs samples. These advancements have deepened our understanding of CVM pathogenesis. Somatic mutations in key mechanistic pathways have been identified as causative factors, leading to a paradigm shift in CVM treatment. Additionally, recent progress in noninvasive and minimally invasive techniques, including gene imaging genomics, liquid biopsy, or endovascular biopsies (endovascular sampling of blood vessel lumens), has enabled the identification of gene variants associated with CVMs. These methods, in conjunction with clinical data, offer potential for early detection, dynamic monitoring, and targeted therapies that could be used as monotherapy or adjuncts to surgery. This review highlights advancements in CVM pathogenesis and precision therapies, outlining the future potential of precision medicine in CVM management.
format Article
id doaj-art-37240d31f0ca4c53bd31b1f591965ece
institution DOAJ
issn 2688-2663
language English
publishDate 2024-12-01
publisher Wiley
record_format Article
series MedComm
spelling doaj-art-37240d31f0ca4c53bd31b1f591965ece2025-08-20T02:46:51ZengWileyMedComm2688-26632024-12-01512n/an/a10.1002/mco2.70027Cerebral vascular malformations: pathogenesis and therapyQiheng He0Ran Huo1Yingfan Sun2Zhiyao Zheng3Hongyuan Xu4Shaozhi Zhao5Yang Ni6Qifeng Yu7Yuming Jiao8Wenqian Zhang9Jizong Zhao10Yong Cao11Department of Neurosurgery Beijing Tiantan Hospital Capital Medical University Beijing ChinaDepartment of Neurosurgery Beijing Tiantan Hospital Capital Medical University Beijing ChinaDepartment of Neurosurgery Beijing Tiantan Hospital Capital Medical University Beijing ChinaDepartment of Neurosurgery Beijing Tiantan Hospital Capital Medical University Beijing ChinaDepartment of Neurosurgery Beijing Tiantan Hospital Capital Medical University Beijing ChinaDepartment of Neurosurgery Beijing Tiantan Hospital Capital Medical University Beijing ChinaDepartment of Neurosurgery Beijing Tiantan Hospital Capital Medical University Beijing ChinaDepartment of Neurosurgery Beijing Tiantan Hospital Capital Medical University Beijing ChinaDepartment of Neurosurgery Beijing Tiantan Hospital Capital Medical University Beijing ChinaDepartment of Neurosurgery Beijing Tiantan Hospital Capital Medical University Beijing ChinaDepartment of Neurosurgery Beijing Tiantan Hospital Capital Medical University Beijing ChinaDepartment of Neurosurgery Beijing Tiantan Hospital Capital Medical University Beijing ChinaAbstract Cerebral vascular malformations (CVMs), particularly cerebral cavernous malformations and cerebral arteriovenous malformations, pose significant neurological challenges due to their complex etiologies and clinical implications. Traditionally viewed as congenital conditions with structural abnormalities, CVMs have been treated primarily through resection, embolization, and stereotactic radiosurgery. While these approaches offer some efficacy, they often pose risks to neurological integrity due to their invasive nature. Advances in next‐generation sequencing, particularly high‐depth whole‐exome sequencing and bioinformatics, have facilitated the identification of gene variants from neurosurgically resected CVMs samples. These advancements have deepened our understanding of CVM pathogenesis. Somatic mutations in key mechanistic pathways have been identified as causative factors, leading to a paradigm shift in CVM treatment. Additionally, recent progress in noninvasive and minimally invasive techniques, including gene imaging genomics, liquid biopsy, or endovascular biopsies (endovascular sampling of blood vessel lumens), has enabled the identification of gene variants associated with CVMs. These methods, in conjunction with clinical data, offer potential for early detection, dynamic monitoring, and targeted therapies that could be used as monotherapy or adjuncts to surgery. This review highlights advancements in CVM pathogenesis and precision therapies, outlining the future potential of precision medicine in CVM management.https://doi.org/10.1002/mco2.70027arteriovenous malformationsbiopsycavernous malformationscerebral vascular malformationmicroenvironmentsomatic mutation
spellingShingle Qiheng He
Ran Huo
Yingfan Sun
Zhiyao Zheng
Hongyuan Xu
Shaozhi Zhao
Yang Ni
Qifeng Yu
Yuming Jiao
Wenqian Zhang
Jizong Zhao
Yong Cao
Cerebral vascular malformations: pathogenesis and therapy
MedComm
arteriovenous malformations
biopsy
cavernous malformations
cerebral vascular malformation
microenvironment
somatic mutation
title Cerebral vascular malformations: pathogenesis and therapy
title_full Cerebral vascular malformations: pathogenesis and therapy
title_fullStr Cerebral vascular malformations: pathogenesis and therapy
title_full_unstemmed Cerebral vascular malformations: pathogenesis and therapy
title_short Cerebral vascular malformations: pathogenesis and therapy
title_sort cerebral vascular malformations pathogenesis and therapy
topic arteriovenous malformations
biopsy
cavernous malformations
cerebral vascular malformation
microenvironment
somatic mutation
url https://doi.org/10.1002/mco2.70027
work_keys_str_mv AT qihenghe cerebralvascularmalformationspathogenesisandtherapy
AT ranhuo cerebralvascularmalformationspathogenesisandtherapy
AT yingfansun cerebralvascularmalformationspathogenesisandtherapy
AT zhiyaozheng cerebralvascularmalformationspathogenesisandtherapy
AT hongyuanxu cerebralvascularmalformationspathogenesisandtherapy
AT shaozhizhao cerebralvascularmalformationspathogenesisandtherapy
AT yangni cerebralvascularmalformationspathogenesisandtherapy
AT qifengyu cerebralvascularmalformationspathogenesisandtherapy
AT yumingjiao cerebralvascularmalformationspathogenesisandtherapy
AT wenqianzhang cerebralvascularmalformationspathogenesisandtherapy
AT jizongzhao cerebralvascularmalformationspathogenesisandtherapy
AT yongcao cerebralvascularmalformationspathogenesisandtherapy